A new drug from Ariad Pharmaceuticals, Inc. may help people with cancer for whom current therapies don’t work, according to a report released today in the scientific journal Cancer Cell.

The paper, which is co-authored by Ariad, describes for the first time how this potential drug may help fight aggressive blood cancers while preventing people from undergoing highly risky transplants.